[The efficacy of using chymotrypsin in the combined treatment of syphilis patients].
Clinical, serologic, and immunologic studies carried out before and after treatment in 102 patients treated with benzylpenicillin according to the scheme developed at the Kuibyshev Medical Institute and chymotrypsin and in 55 patients treated with penicillin alone evidence the efficacy of chymotrypsin. The drug favorably influenced the terms of syphilid regress, negative answers were sooner obtained in classical serologic tests, and the time course of cellular immunologic tests was more favorable.
Chuchunova
T K
TK
D002918:Chymotrypsin / Q000627:therapeutic use*; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D006801:Humans; D007111:Immunity, Cellular / Q000187:drug effects; D010400:Penicillin G / Q000627:therapeutic use; D012008:Recurrence; D012074:Remission Induction; D013587:Syphilis / Q000188:drug therapy* / Q000276:immunology; D013997:Time Factors
D002918:Chymotrypsin; D010400:Penicillin G
Effektivnost' primeneniia khimotripsina v kompleksnom lechenii bol'nykh sifilisom.